Efficacy and safety of azithromycin SR compared with minocycline in acne

Journal of Drugs in Dermatology, August, 2007

Sponsored by Pfizer. The primary objective of this study is to evaluate the clinical efficacy of azithromycin micropheres treatment in outpatients with moderate to severe inflammatory acne compared with first-line treatment minocycline after 8 weeks of therapy.

Condition      Intervention                     Phase

Acne Vulgaris  Drug: Azithromycin microspheres  Phase III

Study ID Numbers: A0661150

ClinicalTrials.gov Identifier: NCT00392223